Company Overview of Actelion Pharmaceuticals Ltd
Actelion Pharmaceuticals Ltd. provides drug discovery and development services. The company develops drugs for pulmonary arterial hypertension treatments that cover the spectrum of diseases ranging from WHO functional class (FC) II through to FC IV, with oral, inhaled, and intravenous medications. It also provides Tracleer, an endothelin receptor antagonist; Veletri (epoprostenol for injection), an intravenous prostacyclin; Ventavis, an inhaled formulation of iloprost; Valchlor (mechlorethamine) gel that is to be applied topically once-a-day and dries on the skin; and ZAVESCA (Miglustat), an oral molecule for the treatment of type 1 Gaucher disease. The company was founded in 1997 and is hea...
Founded in 1997
Key Executives for Actelion Pharmaceuticals Ltd
Actelion Pharmaceuticals Ltd does not have any Key Executives recorded.
Actelion Pharmaceuticals Ltd Key Developments
Gour Medical SA Enters into a Definitive Worldwide License Agreement with Actelion Pharmaceuticals Ltd
Mar 10 15
Gour Medical SA announced that it has entered into a definitive worldwide license agreement with Actelion Pharmaceuticals Ltd. for the veterinary development of one of Actelion’s early-stage clinical dual orexin receptor antagonists, which the company had decided not to pursue further. Under the terms of the agreement Actelion will receive an upfront payment and will be eligible to receive further payments subject to potential development and regulatory milestones, as well as royalties on sales if the compound is commercialized.
Actelion Pharmaceuticals Ltd Presents at 8th Annual EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION, Mar-03-2015 08:30 AM
Feb 18 15
Actelion Pharmaceuticals Ltd Presents at 8th Annual EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION, Mar-03-2015 08:30 AM. Venue: Hilton, Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152 Zurich, Zurich, Switzerland. Speakers: Nicolas Franco, Executive Vice President & Chief Business Development Officer.
Actelion Pharmaceuticals Ltd Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015
Dec 24 14
Actelion Pharmaceuticals Ltd Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions